US FDA considers publicising data on pending applications
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has announced a second meeting of its transparency task force that was set up earlier this year1,2. The move is in line with President Barack Obama’s commitment to achieve “an unprecedented level of openness in Government”3.